NCT00256139View on ClinicalTrials.gov

CLEAR Study: Clinical Experience Acquired With Raptiva Study

PHASE3CompletedINTERVENTIONAL
Enrollment

793

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Moderate to Severe Psoriasis
Interventions
DRUG

Raptiva

Trial Locations (1)

1202

Serono International SA, Geneva

All Listed Sponsors
lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT00256139 - CLEAR Study: Clinical Experience Acquired With Raptiva Study | Biotech Hunter | Biotech Hunter